Noninvasive Methods in Diagnosing Coronary Heart Disease in Diabetic Patients
NCT ID: NCT01179165
Last Updated: 2017-03-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
104 participants
OBSERVATIONAL
2011-01-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiovascular Risk Assessment in a Cohort of Italian Patients With Type 1 Diabetes Mellitus (CARDT1)
NCT06290544
"Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population
NCT02248311
Cardiac Dysfunction in Adolescents With Type 1 Diabetes: Contribution of Daily-life Glucoregulation and Impact on Cardiorespiratory Exercise Capacity
NCT04052919
cArdiopulmonary exerCise Test Assessing Multiple bIOmarkers iN Type 1 Diabetes
NCT05097339
Activation Innate Immune System in Type 1 Diabetes
NCT03441919
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Type 2 diabetes age 40-75
Only one diagnostic/observational group
Diagnostic
Diagnostic non-invasive tests:Dopplerechocardiography, cardiac MRI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diagnostic
Diagnostic non-invasive tests:Dopplerechocardiography, cardiac MRI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age at diagnosis \> 30 years
* Age at inclusion 40-75 years
Exclusion Criteria
* Coronary angiography/stress-test diagnostic of coronary artery disease last 3 years
* Previous myocardial infarction, coronary bypass operation/PCI or heart failure
* Clinical indication for stress -testing
* Active bronchospasm excluding use of adenosine
* eGFR \< 30 ml/min/m2
* short estimated life expectancy due to cancer, chronic liver/renal diseases
40 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Volda Hospital
OTHER
Norwegian University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Torstein L Hole, MD, PhD
Role: STUDY_CHAIR
Norwegian University of Science and Technology
Rune Wiseth, Md, Phd
Role: STUDY_CHAIR
Norwegian University of Science and Technology
Svein Hareide, MD
Role: PRINCIPAL_INVESTIGATOR
Norwegian University of Science and Technology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Volda Hospital HF
Volda, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
83FU18-09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.